Medicines360 recognizes the importance of reproductive justice. We are aligned with the framework defined by SisterSong Women of Color Reproductive Justice Collective as “the human right to maintain
personal bodily autonomy, have children, not have children, and parent the children we have in safe and sustainable communities.”
The National Women’s Health Network (NWHN) and SisterSong issued a Joint Statement of Principles on Long-Acting Reversible Contraceptives (LARCs) in 2016, detailing principles to guide clinicians, professional associations, public health agencies, funders, and others, stating that “Our guiding principles are that we strongly support the inclusion of LARCs as part of a well-balanced mix of options, but we reject efforts to direct women toward any particular method. Only affordable coverage of all options — and a comprehensive, medically accurate, and culturally competent discussion of them — will ensure treatment of the whole human being and truly meet the health and life needs of every woman.” This includes understanding that the provision of LARCs occurs within a historical context of reproductive coercion of people of color, Indigenous people, immigrants, low-income and uninsured people, LGBTQ people, incarcerated people, and people with disabilities.
At Medicines360, we support these principles by believing that all decisions about family planning, for LARCs and other methods, should be free from coercion and pressure, including the availability of and removal of contraceptive devices. Achieving experiences free from coercion requires necessary action by health care and social services providers, policy makers, and many others to ensure that contraceptive options are made available in the context of comprehensive, culturally appropriate ways. Competent counseling, along with the full range of affordable health care and other services is required to support adequate choice in family planning.
©2022 Medicines360. A 501(c)(3) tax-exempt organization. Medicines360® and its design are registered trademarks of Medicines360.
Avibela® is a registered trademark of Medicines360 in countries across Africa, South and Southeast Asia, Central America, and the Caribbean.
Impact RH360® is a registered trademark of Medicines360 in Madagascar, Rwanda, Uganda, South Africa, and Zambia.
All other trademarks are property of their respective owners.